Section 38a-513b - Coverage and notice re experimental treatments. Appeals(a) Each group health insurance policy delivered, issued for delivery, renewed, amended or continued in this state shall define the extent to which it provides coverage for experimental treatments.(b) No such health insurance policy may deny a procedure, treatment or the use of any drug as experimental if such procedure, treatment or drug, for the illness or condition being treated, or for the diagnosis for which it is being prescribed, has successfully completed a phase III clinical trial of the federal Food and Drug Administration.(c) Any person who has been diagnosed with a condition that creates a life expectancy in that person of less than two years and who has been denied an otherwise covered procedure, treatment or drug on the grounds that it is experimental may request an expedited appeal as provided in section 38a-591e and may appeal a denial thereof to the Insurance Commissioner in accordance with the procedures established in section 38a-591g.Conn. Gen. Stat. § 38a-513b
( P.A. 99-284, S. 16, 60; P.A. 11-58, S. 82; P.A. 12-145, S. 44.)
Amended by P.A. 12-0145, S. 44 of the the 2012 Regular Session, eff. 6/15/2012.Amended by P.A. 11-0058, S. 82 of the the 2011 Regular Session, eff. 7/1/2011. See Sec. 38a-483c for similar provisions re individual policies.